A Look Into Healthcare Sector Value Stocks
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock?
价值股票的定义是什么?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
传统上,价值股的定义是市场上投资者如何估值该公司的未来增长前景。低市盈倍数是很好的基本指标,表明该公司的估值被低估,很可能被标记为价值股。
Below is a list of notable value stocks in the healthcare sector:
以下是医疗保健行业值得注意的价值股票清单:
- Exicure (NASDAQ:XCUR) - P/E: 0.33
- Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.69
- BioNTech (NASDAQ:BNTX) - P/E: 8.4
- TherapeuticsMD (NASDAQ:TXMD) - P/E: 0.49
- Viatris (NASDAQ:VTRS) - P/E: 7.05
- Exicure(纳斯达克股票代码:XCUR)——市盈率:0.33
- 基奥拉制药(纳斯达克股票代码:KPRX)——市盈率:0.69
- BioNTech(纳斯达克股票代码:BNTX)——市盈率:8.4
- TherapeuticSMD(纳斯达克股票代码:TXMD)——市盈率:0.49
- Viatris(纳斯达克股票代码:VTRS)——市盈率:7.05
This quarter, Exicure experienced an increase in earnings per share, which was $-0.7 in Q1 and is now $-0.68. Most recently, Kiora Pharmaceuticals reported earnings per share at $-0.89, whereas in Q2 earnings per share sat at $-0.79. Most recently, BioNTech reported earnings per share at $0.73, whereas in Q2 earnings per share sat at $-0.86. Most recently, TherapeuticsMD reported earnings per share at $-0.13, whereas in Q2 earnings per share sat at $-0.24. Viatris has reported Q3 earnings per share at $0.79, which has increased by 5.05% compared to Q2, which was 0.75. Most recently, the company reported a dividend yield of 5.18%, which has increased by 0.59% from last quarter's yield of 4.59%.
本季度,Exicure的每股收益有所增加,第一季度为-0.7美元,目前为-0.68美元。最近,Kiora Pharmicals公布的每股收益为-0.89美元,而第二季度每股收益为-0.79美元。最近,BioNTech公布的每股收益为0.73美元,而第二季度每股收益为-0.86美元。最近,TherapeuticSMD公布的每股收益为-0.13美元,而第二季度的每股收益为-0.24美元。维亚特里斯报告称,第三季度每股收益为0.79美元,与第二季度的0.75美元相比增长了5.05%。最近,该公司公布的股息收益率为5.18%,较上个季度的4.59%的收益率增长了0.59%。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
这5只价值股是Benzinga Insights根据量化分析选择的。尽管这种有条理的判断过程并不意味着做出最终决定,但我们的技术可以让投资者对该行业有更多的认识。